Tyra Biosciences, Inc. · NASDAQ:TYRA
Harris Todd received 864 Tyra Biosciences, Inc. shares as an award (Form 4)
Traded Sep 15, 2026 · Filed Sep 17, 2026
On Sep 15, 2026, Harris Todd (Director, President and CEO) received 864 Tyra Biosciences, Inc. shares as an award at US$9.13 for US$7,888, leaving 1,438,495 shares. Filed Sep 17, 2026 (Form 4).
- Awarded
- 864 shares
- Price
- US$9.13
- Value
- US$7,888
- Holding after
- 1,438,495 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | Award | 864 | US$9.13 | 1,438,495 | Direct |
Source
Related
- Tyra Biosciences, Inc.
- Harris Todd
- Tyra Biosciences, Inc. shareholders
- Form 4 · Harris Todd · May 7, 2026
- Schedule 13G · Biotechnology Value Fund L P · Sep 21, 2026
- Form 4 · Rueb Yuliya · Sep 17, 2026
- Form 4 · Fuhrman Alan · Sep 17, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 17, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Sep 17, 2026